Search

Search Constraints

You searched for: Author/Creator Pietri, Elisabetta

Search Results

1. A Phase II Study of a Dose-Density Regimen With Fluorouracil, Epirubicin, and Cyclophosphamide on Days 1 and 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer. (30th January 2015)

2. A Phase II Study of a Dose‐Density Regimen With Fluorouracil, Epirubicin, and Cyclophosphamide on Days 1 and 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer. (30th January 2015)

4. Androgen and oestrogen receptors as potential prognostic markers for patients with ductal carcinoma in situ treated with surgery and radiotherapy. Issue 5 (28th November 2017)

5. Androgen receptor signaling pathways as a target for breast cancer treatment. Issue 10 (October 2016)

6. P-92 GPS as a prognostic index and a predictor of toxicity in early or locally advanced head and neck cancer patients treated with radiotherapy or definitive chemoradiotherapy. (July 2021)

7. Phase II Study of Dehydroepiandrosterone in Androgen Receptor‐Positive Metastatic Breast Cancer. (27th December 2018)

8. Trastuzumab-induced cardiotoxicity in early breast cancer patients: a retrospective study of possible risk and protective factors. Issue 9 (24th January 2013)

9. Uncovering the genomic heterogeneity of multifocal breast cancer. Issue 4 (7th May 2015)